You are here:
Protecting patients

Medical know-how

At Kendle, we bring the right therapeutic expertise to your program, providing timely medical monitoring and adverse event review to ensure patient safety and regulatory compliance.

Why Kendle?

Kendle has a strong presence throughout North America, Europe, Asia/Pacific, Latin America and Africa, so wherever you are and whatever you need, we have the right medical expert with the right therapeutic expertise for you. Our geographic diversity is derived from our network of expert physicians in all major therapeutic areas, across both traditional and emerging markets. We’re among the leading global providers of Phase I-IV clinical study services, with a focus on expanding our expertise in the top five therapeutic areas: cardiology, central nervous system, infectious diseases, oncology and inflammatory diseases.

Our experience in the traditional markets of North America and Europe is strong, where, for example, our anti-inflammatory experience is second to none. In addition, we’ve conducted numerous studies for bronchitis and chronic obstructive pulmonary disease as well as more than 50 asthma studies (some pediatric). In addition, we continue to grow our presence and experience in emerging markets.

One-stop shop

With our large global footprint and broad expertise, Kendle can assist with all of your clinical trial needs. We understand the unique demands of various studies and our operational staff and medical and scientific specialists have managed all aspects of the development process from clinical through post-approval, including design, execution, analysis and interpretation of studies and their outcomes. We understand, anticipate, adapt and deliver services while staying attuned to the novel therapeutic nuances of each indication and your goals.

Best in Class

Kendle’s key differentiator is our people. Ready to begin work on your clinical trial on day one, our team will drive your study toward a successful outcome. Strategically located across the world, we have an extensive network of physician investigators and a database of ideal sites with relevant patient bases.

A snapshot

Here’s just a glimpse of some of our most recent successes:

  • The largest-ever study of adjunctive therapies for severe chemotherapy-induced nausea and vomiting
  • A large gastrointestinal study recruiting 1,700 patients in 16 countries
  • A complex pediatric hepatitis study of 150 subjects in six countries

Whatever your therapeutic area or study requirements, you can have complete confidence in Kendle as your clinical development partner.

 

 

Read more about our medical know-how

Remind me of your early stage expertise

Remind me of your late stage expertise